.
.
.
.

‘No evidence’ of higher blood clots risk from vaccine: AstraZeneca

Published: Updated:

UK-based drugs company AstraZeneca insisted on Friday its coronavirus vaccine was safe, after some countries suspended its use in response to concerns about a potential link to blood clots.

“An analysis of our safety data of more than 10 million records has shown no evidence of an increased risk of pulmonary embolism or deep vein thrombosis in any defined age group, gender, batch or in any particular country” from the jab, a company spokesperson said.

For more coronavirus news, visit our dedicated page.

“In fact, the observed number of these types of events are significantly lower in those vaccinated than would be expected among the general population.”

Denmark, Iceland, Norway and Bulgaria have temporarily suspended AstraZeneca COVID-19 vaccine shots after reports of cases of blood clots forming, including one in Denmark.

The World Health Organization said Friday there was no reason to stop using AstraZeneca’s COVID-19 vaccine after several European countries suspended the roll-out over blood clot fears.

“Yes, we should continue using the AstraZeneca vaccine,” WHO spokeswoman Margaret Harris told reporters, adding: “There is no indication to not use it.”